News

Sale is still live until July 7. For a limited time, you can find items from brands like Hoka and Yeti at some of their lowest prices.
Regeneron and Teva have announced positive top-line phase 3 results from their fasinumab, as the companies chase Pfizer and Lilly in the race to market a new class of non-opioid painkillers.